S111: REPEATED INFUSIONS OF ESCALATING DOSES OF EXPANDED AND ACTIVATED AUTOLOGOUS NATURAL KILLER CELLS IN MINIMAL RESIDUAL DISEASE-POSITIVE PH+ ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS. A GIMEMA PHASE 1 TRIAL

• G. F. Torelli,
• S. Chiaretti,
• N. Peragine,
• W. Barberi,
• L. Santodonato,
• G. D’Agostino,
• E. Abruzzese,
• M. I. Del Principe,
• A. Mancino,
• M. Matarazzo,
• M. S. Bafti,
• M Mancini,
• M. Messina,
• L. Castiello,
• A. Guarini,
• R. Foà

Affiliations

G. F. Torelli

1 Hematology, Department of Translational and Precision Medicine, Sapienza University

S. Chiaretti

1 Hematology, Department of Translational and Precision Medicine, Sapienza University

N. Peragine

1 Hematology, Department of Translational and Precision Medicine, Sapienza University

W. Barberi

1 Hematology, Department of Translational and Precision Medicine, Sapienza University

L. Santodonato

2 FaBioCell Cell Factory, Istituto Superiore di Sanità

G. D’Agostino

2 FaBioCell Cell Factory, Istituto Superiore di Sanità

E. Abruzzese

3 Hematology, Sant’Eugenio Hospital, ASL Roma2, Tor Vergata University

M. I. Del Principe

4 Hematology, Department of Biomedicine and Prevention, Tor Vergata University

A. Mancino

5 Fondazione GIMEMA Onlus, Rome, Italy

M. Matarazzo

1 Hematology, Department of Translational and Precision Medicine, Sapienza University

M. S. Bafti

1 Hematology, Department of Translational and Precision Medicine, Sapienza University

M Mancini

1 Hematology, Department of Translational and Precision Medicine, Sapienza University

M. Messina

5 Fondazione GIMEMA Onlus, Rome, Italy

L. Castiello

2 FaBioCell Cell Factory, Istituto Superiore di Sanità

A. Guarini

1 Hematology, Department of Translational and Precision Medicine, Sapienza University

R. Foà

1 Hematology, Department of Translational and Precision Medicine, Sapienza University